Pharmaceutical Executive
September 04, 2008
News Analysis
0
0
After a year of layoffs and restructuring, Valeant Pharma scores big with a collaboration deal worth up to $670 million.
September 04, 2008
News Analysis
0
0
The Belgium-based drug maker is terminating 2,000 jobs and rebranding itself as a biopharm with a focus on CNS and immunology drugs. Pharm Exec gave UCB a call to find out more.